Related Experiment Video
Updated: May 13, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Acquired Amphotericin B Resistance Attributed to a Mutated ERG3 in Candidozyma auris
Lauryn Massic1,2, Laura A Doorley3, Sarah J Jones3
1Nevada State Public Health Laboratory, Reno, Nevada, USA.
Abstract:
First identified in 2009, Candidozyma auris (formerly Candida auris) is an emerging multidrug resistant fungus that can cause invasive infections with a crude mortality rate ranging from 30-60%. Currently, 30-50% of C. auris isolates are intrinsically resistant to amphotericin B. In this work, we characterized a clinical case of acquired amphotericin B resistance using whole genome sequencing, a large-scale phenotypic screen, comprehensive sterol profiling, and genotypic reversion using CRISPR. Data obtained in this work provides evidence that a deletion resulting in a frameshift in ERG3 contributes to the observed resistant phenotype. Characterization of this isolate also revealed a fitness cost is associated with the abrogation of ergosterol production and its replacement with other late-stage sterols. This article presents a clinical case description of amphotericin B resistance from a frameshift mutation in ERG3 in C. auris and marks an advancement in the understanding of antifungal resistance in this fungal pathogen.
Insights
Candida auris, a multidrug-resistant fungus, can develop resistance to amphotericin B. A frameshift mutation in the ERG3 gene was identified as a cause of this acquired resistance in a clinical case.
Area of Science:
- Mycology
- Infectious Diseases
- Antifungal Resistance
Background:
- Candida auris is an emerging multidrug-resistant fungal pathogen.
- It causes invasive infections with high mortality rates (30-60%).
- Many C. auris isolates exhibit intrinsic resistance to amphotericin B (30-50%).
Purpose of the Study:
- To characterize a clinical case of acquired amphotericin B resistance in Candida auris.
- To investigate the genetic and molecular mechanisms underlying this resistance.
Main Methods:
- Whole genome sequencing
- Large-scale phenotypic screening
- Sterol profiling
- CRISPR-based genotypic reversion
Main Results:
- A deletion causing a frameshift mutation in the ERG3 gene was identified.
- This ERG3 mutation contributes to acquired amphotericin B resistance.
- Ergosterol production abrogation and replacement with other sterols incur a fitness cost.
Conclusions:
- A frameshift mutation in ERG3 is associated with acquired amphotericin B resistance in C. auris.
- Understanding antifungal resistance mechanisms is crucial for managing C. auris infections.
- This study advances knowledge of antifungal resistance in this critical fungal pathogen.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Mismatch Repair
Mutations
Genome Copying Errors
Viral Mutations

